跳至主要内容
临床试验/ACTRN12614000180617
ACTRN12614000180617终止3 期

A Double-blind Randomised, Placebo-controlled Trial to Assess the Efficacy of Loperamide versus Placebo as Post-operative Prevention of High Output Ileostomy Losses in Patients with New Loop Ileostomy.

Hunter New England Local Health District0 个研究点目标入组 86 人开始时间: 2014年2月17日最近更新:

试验速览

阶段
3 期
状态
终止
入组人数
86

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Written informed consent
  • -All adult (>18 years) patients undergoing elective or semi-urgent booked operations involving a loop ileostomy at the participating hospitals.
  • -Must have passed flatus post-operatively, tolerating diet and no signs and symptoms of ileus.

排除标准

  • -Refuse or are unable to give written informed consent to participate in the study, or
  • -Have a known allergy or adverse drug reaction to loperamide
  • -Pregnant or lactating females
  • -Have a eGFR less than 60ml/min/1.73m3 pre-operatively

研究者

相似试验

进行中(未招募)
不适用
A Double-Blind Randomised Placebo-Controlled Trial of Vitamin D Supplements for Pregnant Women with Low Levels of Vitamin D in Early Pregnancy - MAVIDOSMedDRA version: 9.1Level: LLTClassification code 10005991Term: Bone mass decreasedOsteoporosis
EUCTR2007-001716-23-GBSouthampton University Hospitals NHS Trust1,000
进行中(未招募)
1 期
A study to compare the use of ferric carboxymaltose with placebo in patients with acute heart failure and iron deficiencyAcute heart failure with iron deficiencyMedDRA version: 20.0Level: SOCClassification code 10007541Term: Cardiac disordersSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: LLTClassification code 10000803Term: Acute heart failureSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: PTClassification code 10022970Term: Iron deficiencySystem Organ Class: 10027433 - Metabolism and nutrition disorders
EUCTR2016-001467-36-PLVifor (International) Inc.650
进行中(未招募)
1 期
A study to compare the use of ferric carboxymaltose with placebo in patients with acute heart failure and iron deficiencyAcute heart failure with iron deficiencyMedDRA version: 20.0Level: SOCClassification code 10007541Term: Cardiac disordersSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: LLTClassification code 10000803Term: Acute heart failureSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: PTClassification code 10022970Term: Iron deficiencySystem Organ Class: 10027433 - Metabolism and nutrition disorders
EUCTR2016-001467-36-ESVifor (International) Inc.1,110
进行中(未招募)
1 期
A study to compare the use of ferric carboxymaltose with placebo in patients with acute heart failure and iron deficiency
EUCTR2016-001467-36-NLVifor (International) Inc.1,110
进行中(未招募)
1 期
A study to compare the use of ferric carboxymaltose with placebo in patients with acute heart failure and iron deficiencyAcute heart failure with iron deficiencyMedDRA version: 20.0Level: LLTClassification code 10000803Term: Acute heart failureSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: SOCClassification code 10007541Term: Cardiac disordersSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: PTClassification code 10022970Term: Iron deficiencySystem Organ Class: 10027433 - Metabolism and nutrition disorders
EUCTR2016-001467-36-ITVIFOR (INTERNATIONAL) INC.1,110